Trials / Recruiting
RecruitingNCT07205445
Tensi+ European Registry
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Stimuli Technology · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Tensi+ (Stimuli Technology, Boulogne Billancourt, France) is a newly released, medical transcutaneous-posterior tibial nerve stimulation (TC-pTNS) device marketed for overactive bladder (OAB) management. Preliminary studies have shown a favorable safety and efficacy profile. The goal of the present registry is to collect data among an important number of patients to assess the efficacy, safety and potential predictive factors of success in a current clinical setting over a total period of 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tensi+ | Tensi+ (Stimuli Technology, Boulogne Billancourt, France) is a newly released, medical transcutaneous-posterior tibial nerve stimulation (TC-pTNS) device marketed for overactive bladder (OAB) management. |
Timeline
- Start date
- 2025-02-27
- Primary completion
- 2027-10-01
- Completion
- 2027-10-01
- First posted
- 2025-10-03
- Last updated
- 2025-10-03
Locations
17 sites across 3 countries: France, Italy, United Kingdom
Source: ClinicalTrials.gov record NCT07205445. Inclusion in this directory is not an endorsement.